Advanced Materials and Drug Delivery
The Advanced Materials and Drug Delivery Cluster Area seeks to create and apply cutting-edge biomaterials for high-impact biomedical applications and to create paradigm-changing approaches and systems for advanced drug delivery.
Novel biomaterials are created to solve critical issues of the field: guide tissue regeneration, design highly selective, robust and biocompatible sensors, and alter surface chemistry to improve tissue/device interfaces. Likewise, we thrive to deliver difficult drugs (proteins, peptides, siRNA, insoluble anticancer drugs, vaccine antigens) in a targeted manner and to hard-to- reach places (cancer cells, brain, eye, lymph nodes) for prolonged periods of time (controlled release) in order to maximize therapeutic efficacy.
Our efforts in biomaterials include designing novel polymer-protein and polymer lipid composites for sensing of influenza virus, prostate cancer antigen and antibiotics. Surface engineering of biomaterials can lead to creation of non-wettable surfaces to control protein and cell adhesion, stem cell culture and differentiation. We blend and modify biocompatible polymers to improve mucoadhesion and stability of entrapped drug molecules. We cross-link phospholipid bilayers and develop lipid-peptide complexes to alter cell processing of biomaterials. We collectively contributed to an extensive toolbox of drug delivery platforms such as mucoadhesive gels, biodegradable implants, multicompartmental polymer nanoparticles, cross-linked liposomes for antigen delivery, and lipoprotein nanodisks. These platform technologies deliver a wide range of drug molecules and vaccine antigens with a focus on large molecule stability and delivery.
Multi-phasic particles of different shapes can be manufactured with precise control over particles geometry by the Wettability Engendered Templated Self-assembly (WETS) method.
Related Press Releases & Articles
- October 8 @ 12:00 pm
Neuroregeneration and Cognition Challenge Save The Date
Save the Date for a joint Biointerfaces Institute and Michigan Neuroscience Institute Joint Challenge on “Neuroregeneration and Cognition” on October 8 and 9, 2021.
- July 22, 2021 / Press Release
BioInnovations in Brain Cancer launches faculty search
The BioInnovations in Brain Cancer Initiative (BIBC) at the University of Michigan invites applications for a tenure-track position at any level in brain cancer biology and technology research (including, drug/molecular transport/imaging in the brain tissue; translation-focused glioma, epigenetics and/or scRNA-seq research; and non-viral nucleic acid delivery).
Applications will be accepted on a rolling basis, but review of applications will begin on October 1, 2021.
- July 20, 2021 / Article
Tuteja Lab publishes review on repellent surface in Science
The Tuteja lab publishes a new review in Science on liquid-repelling surfaces and coatings.
- June 25, 2021 / Press Release
Tessier Lab Discovers New Protein Engineering Method
Researchers in the Tessier lab found a simple method for identifying nanobodies with drug-like properties suitable for preventing COVID-19 infections, which likely can be used to develop nanobodies against other viruses and disease targets.
- May 21, 2021 / Press Release
Faculty Promotions
Congratulations to James Moon, Sunitha Nagrath, Anna Schwendeman and Anish Tuteja on being promoted to Professor!
- May 17, 2021 / Award
2021 BI Innovator Awardees
Congratulations to the 2020 BI Innovator Award Recipients. BI Innovator awards recognize members of the BI research community who are active participants in the research, innovation and translational ecosystem at BI and making a difference in our community.
- April 7 @ 1:00 pm
BI Distinguished Lectureship Series with Dr. David A. Weitz
Join us on April 7 for a Distinguished Lecture by Dr. David A. Weitz.
- April 1, 2021 / Article
Recent BI Publications
Publications from BI Research Groups in March
- March 1, 2021 / Article
Recent BI Publications
Publications from BI Research Groups in February
- February 1, 2021 / Article
Recent BI Publications
Publications from BI Research Groups in January
- December 9, 2020 / Award
Nick Kotov Elected to National Academy of Inventors
Professor Nick Kotov was elected to the 2020 Class of Fellows by the National Academy of Inventors
- December 1, 2020 / Article
Recent BI Publications
Publications from BI Research Groups in November
- October 30, 2020 / Article
Recent BI Publications
Publications from BI Research Groups in October
- September 30, 2020 / Article
Recent BI Publications
Publications from BI Research Groups in September
- September 30, 2020 / Press Release
FDA awards $5M to establish new Center for Research on Complex Generics
Researchers from the University of Michigan and the University of Maryland were awarded a $5 million grant to establish a new Center for Research on Complex Generics. BI Faculty Professor Anna Schwendeman will be the center co-director along with Professor James Polli from the University of Maryland.
The center is funded by the FDA Office of Generic Drugs and aims at bringing complex generic drugs and drug products to market faster.
- July 31, 2020 / Article
Recent BI Publications
Publications from BI Research Groups in July
- June 30, 2020 / Article
Recent BI Publications
Publications from BI Research Groups in June
- June 18, 2020 / Award
Moon Awarded Michigan Drug Discovery Grant
Congratulations to James Moon who received a pilot grant from Michigan Drug Discovery to continue his ongoing work to develop immunotherapy agents for the treatment of cancer.
- May 29, 2020 / Article
Recent BI Publications
Publications from BI Research Groups in May
- March 31, 2020 / Article
Recent BI Publications
Publications from BI Research Groups in March
Our Advanced Materials and Drug Delivery Researchers
Advanced Materials and Drug Delivery Publications
Nanotechnology
Learn MoreCell and Tissue Engineering
Learn MoreSingle Cell Technologies
Learn MoreNeural Engineering
Learn MoreBioInnovations in Brain Cancer
Learn More
Jinsang Kim
Professor of Materials Science and Engineering, Chemical Engineering, Biomedical Engineering, and Macromolecular Science and Engineering and Director of Macromolecular Science and Engineering Program Research Focus: Advanced Materials and Drug Delivery Contact Information:jinsang@umich.eduKim’s Smart Functional Polymer Lab explores functional polymeric materials and their nanostructural assembly to develop advanced polymeric objects. The research focuses on the rational molecular design, chemical and/or biological synthesis, and molecular assembly of functional polymers.
Joerg Lahann
Wolfgang Pauli Collegiate Professor of Chemical Engineering; Professor of Materials Science and Engineering, Biomedical Engineering, and Macromolecular Science and Engineering Research Focus: Single Cell Technologies, Advanced Materials and Drug Delivery, BioInnovations in Brain Cancer Contact Information:lahann@umich.eduResearch in the Lahann Lab focuses on surface engineering, advanced polymers, biomimetic materials, engineered stem cell microenvironments, drug delivery, and nano-scale self-assembly.
Anish Tuteja
Associate Professor of Materials Science and Engineering, Macromolecular Science and Engineering, and Chemical Engineering Research Focus: Advanced Materials and Drug Delivery Contact Information:atuteja@umich.eduThe Tuteja Group research is in surface science, including developing super-omniphobic surfaces (surfaces on which liquids bead up and roll- off). They have developed a novel technique to fabricate nano- and micro- particles of any size, shape, or chemistry. The developed particles’ shape, size, and composition can be used to engineer bio-distribution, skin or lung uptake, intra-cellular localization, and cell response.
Steven Schwendeman
Ara G. Paul Professor and Department Chair of Pharmaceutical Sciences; Professor of Biomedical Engineering Research Focus: Advanced Materials and Drug Delivery, BioInnovations in Brain Cancer Contact Information:schwende@umich.eduThe Schwendeman Group develops advanced polymer-based controlled drug delivery approaches including vaccine delivery from poly(lactic-co-glycolic acid) (PLGA); PLGA nanoparticle formulation; and development of mucoadhesive polymers/formulations for intraoral and intranasal delivery.
James Moon
John G. Searle Associate Professor of Pharmaceutical Sciences; Associate Professor of Biomedical Engineering Research Focus: BioInnovations in Brain Cancer, Advanced Materials and Drug Delivery Contact Information:moonjj@umich.eduThe Moon Group develops therapeutics and diagnostics at the interface of immunology and engineering. Research addresses drug delivery systems for enhancing delivery of antigen and adjuvant to lymphoid organs and manipulating immune functions in the context of cancer, infectious diseases, and autoimmunity.
Peter Tessier
Albert M. Mattocks Professor of Pharmaceutical Sciences; Professor of Chemical Engineering Research Focus: Nanotechnology, Advanced Materials and Drug Delivery, BioInnovations in Brain Cancer Contact Information:ptessier@umich.eduThe Tessier lab aims to develop next generation technologies for designing, discovering, engineering, characterizing, formulating and delivering biologics ranging from small affinity peptides to large monoclonal antibodies for molecular imaging, diagnostic and therapeutic applications.